Found: 15
Select item for more details and to access through your institution.
JP‐1366: A novel and potent potassium‐competitive acid blocker that is effective in the treatment of acid‐related diseases.
- Published in:
- Pharmacology Research & Perspectives, 2023, v. 11, n. 3, p. 1, doi. 10.1002/prp2.1090
- By:
- Publication type:
- Article
CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 4, p. 1473, doi. 10.3390/ijms21041473
- By:
- Publication type:
- Article
Renoprotective Effect of the Histone Deacetylase Inhibitor CG200745 in DOCA-Salt Hypertensive Rats.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 3, p. 508, doi. 10.3390/ijms20030508
- By:
- Publication type:
- Article
Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in healthy subjects.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 7, p. 763, doi. 10.1111/apt.17406
- By:
- Publication type:
- Article
Featured Cover.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 7, p. i, doi. 10.1111/apt.16796
- By:
- Publication type:
- Article
Dissociation/association properties of a dodecameric cyclomaltodextrinase.
- Published in:
- FEBS Journal, 2006, v. 273, n. 1, p. 109, doi. 10.1111/j.1742-4658.2005.05047.x
- By:
- Publication type:
- Article
First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1048, doi. 10.1007/s10637-015-0262-2
- By:
- Publication type:
- Article
A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance.
- Published in:
- Scientific Reports, 2017, p. 41615, doi. 10.1038/srep41615
- By:
- Publication type:
- Article
Amelioration of amyloid β-FcγRIIb neurotoxicity and tau pathologies by targeting LYN.
- Published in:
- FASEB Journal, 2019, v. 33, n. 3, p. 4300, doi. 10.1096/fj.201800926R
- By:
- Publication type:
- Article
In Vitro Metabolism and Transport Characteristics of Zastaprazan.
- Published in:
- Pharmaceutics, 2024, v. 16, n. 6, p. 799, doi. 10.3390/pharmaceutics16060799
- By:
- Publication type:
- Article
The Anti-Fibrotic Effects of CG-745, an HDAC Inhibitor, in Bleomycin and PHMG-Induced Mouse Models.
- Published in:
- Molecules, 2019, v. 24, n. 15, p. 2792, doi. 10.3390/molecules24152792
- By:
- Publication type:
- Article
Histone deacetylase inhibitor, CG200745 attenuates renal fibrosis in obstructive kidney disease.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-30008-5
- By:
- Publication type:
- Article
Modulation of Substrate Preference of Thermus Maltogenic Amylase by Mutation of the Residues at the Interface of a Dimer.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2007, v. 71, n. 6, p. 1564, doi. 10.1271/bbb.70017
- By:
- Publication type:
- Article
TreX from Sulfolobus solfataricus ATCC 35092 Displays Isoamylase and 4-a-Glucanotransferase Activities.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2007, v. 71, n. 5, p. 1348, doi. 10.1271/bbb.70016
- By:
- Publication type:
- Article
Improvement of cyclodextrin glucanotransferase as an antistaling enzyme by error‐prone PCR.
- Published in:
- PEDS: Protein Engineering, Design & Selection, 2004, v. 17, n. 3, p. 205, doi. 10.1093/protein/gzh035
- By:
- Publication type:
- Article